Welcome Guest
Sign In
Register
Home
Bioprocessing
Chromatography
Drug Delivery
Excipients
Formulation Development
Microbiology
Spectroscopy
Articles
Issue Archives
Whitepapers / App Notes / eBooks
Industry Expert
Facility Tour
CGT Circuit
News
Products
Featured Products
New Products
Analytical Equipment
Formulation Development
Pharmaceutical Manufacturing
Excipients
All Other Products
QC Corner
Webinars
Videos
A Solid Dosage Future Documentary
Clean Facility Documentary
Continuous Processing Documentary
Cell and Gene Therapy Documentary
Making Data Work Documentary
Company Profiles
Events
Register
Sign In
Home
Product Center
Pharmaceutical Excipients
Excipients
Excipients
Your search returned 50 Excipient Search across 1 supplier.
Showing 50 of 50 products
<<
<
>
>>
Sort By
- select -
Item Name
Company Name
Price
Select All
Select up to 5 products from below to compare or request more information.
Compare
Kollicoat MAE 100 P
BASF North America
Functionality:
Enteric Release Coating
Application:
Enteric coating with release above pH 5.5 (partially preneutralized powder)
Get quote
Compare
or
Get quote
for selected.
Kollicoat MAE 30 DP
BASF North America
Functionality:
Enteric Release Coating
Application:
Enteric coating with release above pH 5.5 (30 % solids content dispersion)
Get quote
Compare
or
Get quote
for selected.
Kollicoat SR 30 D
BASF North America
Functionality:
Sustained Release Coating
Application:
pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.
Get quote
Compare
or
Get quote
for selected.
Kollicoat Smartseal 30 D
BASF North America
Functionality:
Taste Masking Coating
Application:
Taste masking at very low coating levels, suitable for pellets & particles for ODTs
Get quote
Compare
or
Get quote
for selected.
Kollicoat® IR
BASF North America
Functionality:
Instant Release Coating
Application:
For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.
Get quote
Compare
or
Get quote
for selected.
Kollicoat® MAE 100-55
BASF North America
Functionality:
Enteric Release Coating
Application:
Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating
Get quote
Compare
or
Get quote
for selected.
Kollicream® 3C
BASF North America
Functionality:
Emollient & solvent
Application:
Medium spreadability, extremely mild, solvent for lipophilic drugs, enhances skin penetration
Get quote
Compare
or
Get quote
for selected.
Kollicream® IPM
BASF North America
Functionality:
Emollient & solvent
Application:
Fast spreading with light & fresh feeling, solvent for lipophilic drugs, enhances skin penetration
Get quote
Compare
or
Get quote
for selected.
Kollicream® OA
BASF North America
Functionality:
Emollient & solvent
Application:
Medium spreadability, solvent for lipophilic drugs, enhances skin penetration
Get quote
Compare
or
Get quote
for selected.
Kollicream® OD
BASF North America
Functionality:
Emollient & solvent
Application:
Medium spreadability, solvent for lipophilic drugs, enhances skin penetration, effective in exceptionally wide pH range
Get quote
Compare
or
Get quote
for selected.
Kollidon 90 F
BASF North America
Functionality:
Binder
Application:
Tablet binding, Thickener, Stabilizers of suspensions, Reduces sedimentation, crystallization inhibition
Get quote
Compare
or
Get quote
for selected.
Kollidon SR
BASF North America
Functionality:
Binder
Application:
For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Get quote
Compare
or
Get quote
for selected.
Kollidon VA 64
BASF North America
Functionality:
Binder
Application:
Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.
Get quote
Compare
or
Get quote
for selected.
Kollidon® 12 / 17 PF
BASF North America
Functionality:
Binder
Application:
Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products
Get quote
Compare
or
Get quote
for selected.
Kollidon® 25/Kollidon® 30
BASF North America
Functionality:
Binder
Application:
Binding, Pore Forming, Taste masking, Stabilizer, Thickener, as Solubilizing agent, Crystallization inhibitor, instant release matrices & spray drying
Get quote
Compare
or
Get quote
for selected.
Kollidon® 30 LP
BASF North America
Functionality:
Binder
Application:
Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.
Get quote
Compare
or
Get quote
for selected.
Kollidon® CL / CL-F / CL-SF
BASF North America
Functionality:
Disintegrant
Application:
Maximum disintegration
Get quote
Compare
or
Get quote
for selected.
Kollidon® CL-M
BASF North America
Functionality:
Disintegrant
Application:
Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.
Get quote
Compare
or
Get quote
for selected.
Kollidon® VA64 Fine
BASF North America
Functionality:
Binder
Application:
Binder with fine particle size for roller compaction & direct compression
Get quote
Compare
or
Get quote
for selected.
Kolliphor EL
BASF North America
Functionality:
Solubilizer
Application:
Nonionic emulsifier for O-W emulsions, Solubilizer
Get quote
Compare
or
Get quote
for selected.
Kolliphor ELP
BASF North America
Functionality:
Solubilizer
Application:
For sensitive active ingredients to improve their stability
Get quote
Compare
or
Get quote
for selected.
Kolliphor RH40
BASF North America
Functionality:
Solubilizer
Application:
Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions
Get quote
Compare
or
Get quote
for selected.
Kolliphor® CS 20
BASF North America
Functionality:
Emulsifier
Application:
Nonionic emulsifier for O-W emulsions
Get quote
Compare
or
Get quote
for selected.
Kolliphor® CS L
BASF North America
Functionality:
Emulsifier
Application:
Self-emulsifying and consistency building, easy-to-use base for dermatological creams
Get quote
Compare
or
Get quote
for selected.
Kolliphor® HS 15
BASF North America
Functionality:
Solubilizer
Application:
Nonionic emulsifier for O-W emulsions, Solubilizer
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P 188 Bio
BASF North America
Functionality:
Cell Culture Shear Protectant
Application:
For use as a shear protectant in cell culture manufacturing processes
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P188
BASF North America
Functionality:
Solubilizer
Application:
Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P188 micro
BASF North America
Functionality:
Solubilizer
Application:
Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P407
BASF North America
Functionality:
Solubilizer
Application:
Polymeric solubilizer, emulsifier & plasticizer, Enhances viscosity, thermoreversible gelling effect
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P407 micro
BASF North America
Functionality:
Solubilizer
Application:
Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets
Get quote
Compare
or
Get quote
for selected.
Kolliphor® PS 20 / 60 / 80
BASF North America
Functionality:
Solubilizer
Application:
Nonionic solubilizer, emulsifier and co-emulsifier
Get quote
Compare
or
Get quote
for selected.
Kolliphor® SLS
BASF North America
Functionality:
Emulsifier
Application:
Wetting agent, reduces disintegration time, Ionic solubilizer, high HLB anionic emulsifier for semi-solids and foams
Get quote
Compare
or
Get quote
for selected.
Kolliphor® SLS Fine
BASF North America
Functionality:
Emulsifier
Application:
Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets
Get quote
Compare
or
Get quote
for selected.
Kollisolv P 124
BASF North America
Functionality:
Solubilizer
Application:
Liquid plasticizer for tablet coatings, Solvent for APIs, dispersing agent, stabilizer and co-emulsifier in semi-solid formulations
Get quote
Compare
or
Get quote
for selected.
Kollisolv PEG 300
BASF North America
Functionality:
Solvent
Application:
Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs
Get quote
Compare
or
Get quote
for selected.
Kollisolv PEG 400
BASF North America
Functionality:
Solvent
Application:
Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs
Get quote
Compare
or
Get quote
for selected.
Kollisolv® GTA
BASF North America
Functionality:
Solvent, Plasticizer
Application:
Plasticizer particularly suitable for tablet coatings. Versatile water or oil miscible solvent in topical formulations
Get quote
Compare
or
Get quote
for selected.
Kollisolv® MCT 70
BASF North America
Functionality:
Solubilizer
Application:
Oil fill & solubilizer for lipophilic drugs, Water barrier-repairing, emollient film-former on skin
Get quote
Compare
or
Get quote
for selected.
Kollisolv® PEG 600
BASF North America
Functionality:
Solvent
Application:
Hydrophilic fill for solubilization of hydrophilic APIs
Get quote
Compare
or
Get quote
for selected.
Kolliwax® CA
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Structure-building consistency factor for semi-solids. Viscosity regulator.
Get quote
Compare
or
Get quote
for selected.
Kolliwax® CSA 50
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer
Get quote
Compare
or
Get quote
for selected.
Kolliwax® GMS II
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Co-emulsifier, viscosity enhancer & anti-tacking agent
Get quote
Compare
or
Get quote
for selected.
Kolliwax® HCO
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations
Get quote
Compare
or
Get quote
for selected.
Kolliwax® MA
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Consistency factor with low melting point. Soft sensory effect
Get quote
Compare
or
Get quote
for selected.
Kolliwax® S
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Structure-building consistency factor with dry feel, forms crystalline barrier on skin
Get quote
Compare
or
Get quote
for selected.
Kolliwax® S Fine
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories
Get quote
Compare
or
Get quote
for selected.
Kolliwax® SA
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator
Get quote
Compare
or
Get quote
for selected.
Ludiflash
BASF North America
Functionality:
Binder
Application:
Ready-to-use ODT solution with superior mouthfeel
Get quote
Compare
or
Get quote
for selected.
Ludipress
BASF North America
Functionality:
Binder
Application:
Ready-to-use direct compression solution for tablets
Get quote
Compare
or
Get quote
for selected.
Soluplus
BASF North America
Functionality:
Binder
Application:
Increase solubility and bioavailability, Ideal for hot melt extrusion (HME)
Get quote
Compare
or
Get quote
for selected.
Select All
Select up to 5 products from above to compare or request more information.
Compare
Tags:
Please Login or Register to Create Tags
Feedback
Articles
Klucel™ exf ultra hpc
FlowLac® 90
DuraLac® H
Pearlitol 200GT
Pearlitol 200SD
gelwoRx™ Dsolve portfolio
VIVACOAT® A - Ready-to-Use Coating System
VIVACOAT® free
VIVACOAT® seal
VIVACOAT® ocean-pure
Polyplasdone™ Plus Multifunctional Disintegrant
Aclar® Crystal-clear Barrier Films
Apinovex™ Polymers
Carbopol® Polymers
Enhancing Formulation Development: Leveraging Specialty Chemicals for Improved Drug Delivery
Precision Medicine in Clinical Trials: A Statistical Perspective
Aquarius™ TF Film Coating System
Benecel™ xrf hpc
Process Validation and Sterility Assurance: Relations and Requirements
Understanding and Resolving Drug Shortages in the Pharmaceutical Industry
Maisine® CC
An Update on Oral Administration of Peptides to Achieve Systemic Delivery
The Lifecycle of Drugs from Development to Approval and Market Launch
Keeping Patients in Focus: Limiting Treatment Burden for Improved Eye Care
Pharmaceutical P.I.N. Points: Patent Innovation News - March 2023
Principles of Drug Design: How to Leverage Ligand-Receptor Molecular Interactions
Moving Towards Genome Integrity Evaluation of Gene Therapy Viral Vectors
Pharmaceutical P.I.N. Points: Patent Innovation News - April 2023
Captisol® Modified Cyclodextrin
Labrasol® ALF
Facility Tour: Gattefossé - The Lipid Chemistry Experts
The CDMO’s Challenges for Developing Oral Suspensions for Children
Solid Lipid Nanocarrier Development Toolbox for Increasing Oral Bioavailability of API
Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017
A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
The Innovator Pipeline: Bioavailability Challenges and Advanced Oral Drug Delivery Opportunities
BASF Starts Up tert. Butylamine plant in Nanjing, China
CPhI opens Awards to Global Pharma Industry, Celebrating Tomorrow’s Innovations Today
The Creation of an Excipient Properties Database to Support Quality by Design (QbD) Formulation Development
Controlled Release Pulmonary Therapies: Promises and Concerns
CPhI Report Indicates a Need for Greater Third Party Certification to Ensure GMP Vigilance
Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective
Development of Freeze-dried Formulations Using Thermal Analysis and Microscopy
Quality-by-Design for Freeze-Thaw of Biologics: Concepts and Application to Bottles of Drug Substance
Application Challenges and Examples of New Excipients in Advanced Drug Delivery Systems
Amorphous Solid Dispersions as Enabling Formulations for Discovery and Early Development
Ion Chromatography in USP-NF
Parenteral Products: Pharmacopeial Control of Containers, Storage and Distribution
Evaluation of In-Situ Fiber Optics Dissolution Method for Compound A Extended Release Tablets
Compendial Standards and Excipient Performance in the QbD Era: USP Excipient Performance Chapter <1059>
Davisco Foods International, Inc. and Meggle Group announce a Joint Venture for the Production of Pharmaceutical Lactose
Hot-stage Optical Microscopy as an Analytical Tool to Understand Solid-state Changes in Pharmaceutical Materials
Advances in Lipid-based Formulations: Overcoming the Challenge of Low Bioavailability for Poorly Water Soluble Drug Compounds
Aesica Appoints Ian Muir to Newly Created Commercial Managing Director Position
CPhI Announces USA Market Report at InformEx
An Interview With Jasmine Musakhanian, M.Sc. Marketing & Scientific Director of Pharmaceutical Division Gattefossé USA
CELPHERE MCC Spherical Seed Core
CEOLUS KG Grade Microcrystalline Cellulose
CEOLUS PH Grade Microcrystalline Cellulose
CEOLUS UF Grade Microcrystalline Cellulose
Soluplus
Actimask® Acetaminophen 92M
Gattefossé North America Announces Recipient of 2017 Award for Excellence
An Interview With Shaukat Ali, PhD
ABITEC, UNIVAR Canada Announce Specialty Lipid Distribution Agreement
Tracking Host Cell Proteins During Biopharmaceutical Manufacturing: Advanced Methodologies to Ensure High Product Quality
ABITEC Launches New Versatile Excipient for Oral Dosage Applications
FDA Finalizes Bulk Drug substances Rule
Aquarius™ Genesis Film Coating System
Klucel™ xtend Hydroxypropylcellulose (HPC) Controlled Release Matrix Former
Mechanism of Stabilization of Proteins by Poly-hydroxy Co-solvents: Concepts and Implications in Formulation Development
Miniaturized Equipment for Early Formulation Development
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
In Vitro
High-throughput Drug Precipitation Methods for Oral Formulations
An Interview with DSM
Why is GMP Training a Necessity at Excipient Sites?
Stability Testing – Doing Everything or Doing the Right Thing?
Aptalis Pharmaceutical Technologies Sponsors 2012 Controlled Release Society’s Young Investigator Award at Annual Meeting and Exposition
Using Process Analytical Technologies for Real Time Monitoring and Quality Assurance in Chemical Development
Functionality and Performance of Excipients in a Quality-by-Design World Part X: Continuous Processing of Pharmaceutical Finished Products
Functionality and Performance of Excipients in a Quality-by-Design World, Part IX: New Excipients
New VitalDose® Blog Debuts
Functionality and Performance of Excipients in Quality-by-Design World, Part VIII: Excipient Specifications
Functionality and Performance of Excipients in Quality-by-Design World, Part VII: Quality Risk Management
Functionality and Performance of Excipients in Quality-by-Design World Part VI: Excipient Composition
Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co. Ltd. and Extensive Investments to it's Zydis® to Technology Capabilities in Swindon, UK
Functionality and Performance of Excipients in Quality-by-Design World Part V: Changes in the Sourcing and Supply of Pharmaceutical Excipients
An Interview with Meggle
An Interview with DSM
Use of Enzymes in the Dissolution Testing of Gelatin Capsules
The Impact of USP’s New Elemental Impurities Standards on Manufacturers, Suppliers and Contract Laboratories
BASF Extends Offer Period for Pronova BioPharma
BASF Increases Cash Offer for Pronova BioPharma
Viscosity Modifier Excipients
Stabilizer Excipients
pH Modifier Excipients
Effervescent Excipients
Dry Powder Inhalation Excipients
Surfactant Excipients
Preservative Excipients
Solubility Enhancement Excipients
Emulsifier Excipients
Plasticizer Excipients
Solubilizer Excipients
Binder Excipients
Co-processed Excipients
Disintegrant Excipients
Taste Masking Excipients
Diluent Excipients
Effervescent System Excipients
Filler Excipients
Coating Systems Excipients
Sweetener Excipients
Rapid Release Agent Excipients
Thickener Excipients
Active Pharmaceutical Ingredient Excipients
Lubricant Excipients
Controlled Release Excipients
Hot Melt Extrusion Excipients
Carrier Excipients
Natural Origin Excipients
Increased Bioavailability Excipients
Film Former Excipients
Direct Compression Excipients
Capsule Filling Excipients
Tablet Compressibility Excipients
Liquid Excipients
Solvent Excipients
Film Excipients
Powder Excipients
Lipid Excipients
Granulation Excipients
Multifunctional Excipients
Dispersion Excipients
An Interview With... Dr. Egmont G. Pfeifer and Dr. Albrecht Krämer of MEGGLE Group
World’s First Triple Compound: CombiLac® from Meggle
Lipids in Transdermal and Topical Drug Delivery
Roundtable: Excipient Trends/Challenges
Forensics in QbD: Addressing Foreign Particulate Matter Investigations
Hydroxypropyl Cellulose for Orally Disintegrating Film Drug Application
Micromeritics to Participate in University of Maryland Tableting Course
Natoli Debuts New Website
First GMP-Compliant Batch of a Biologic Drug Substance from a Moss Expression System Produced for Clinical Use
Catalent Announces Two Senior Executive Appointments to Support Global Development and Clinical Services Business Growth
Almac Doubles Global 2-8°C Cold Room Capacity in Response to Increasing Biologics Demand
Almac Makes Further Significant co-investment to Meet Japanese Client Demand for Humidity Controlled Blister Packaging
BASF and Colorcon Cooperate on Kollicoat
®
IR for Ready-to-Use Pharmaceutical Coating Solutions
Pharmaceutical Excipients Identification With Handheld Raman
BASF to Build New World-scale Plant for Specialty Amines in Ludwigshafen
Quotient Clinical Extends its Translational Pharmaceutics™ Platform into Cancer Drug Development
Taste Masking Techniques in the Pharmaceutical Industry
Trends and Innovations in Oral Drug Delivery Round Table
EMD Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products
Noramco, SPI Pharma Announce Availability of Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms
Modified Release Excipients
Penetration Enhancer Excipients
Permeation Enhancer Excipients
Compaction Excipients
Croda Celebrates EXCiPACTTM “Double”
CPhI Pharma Awards Winners Showcase the Innovations Driving Pharma
Thermo Fisher Scientific Receives Clearance from the European Commission for its Acquisition of Life Technologies
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
Catalent Pharma Solutions and Adamas Pharmaceuticals Enter Into Phase 3 Clinical Trials Manufacturing Agreement for Potential New Treatment for Levodopa Induced Dyskinesia
BASF Received EXCiPACTTM Certification as Pharmaceutical Excipient Supplier
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
Particle Engineering For Improved Bioavailability In Oral Solid Dose Medications
Dry Granulation Excipients
Wet Granulation Excipients
Microbiologics Announces New CEO
Case Study: LUBRITAB® RBW Direct Compression Tableting
Whitepaper: VOC Reducing Additives for Masterbatches and Final Polymer Articles
Ginkgo Bioworks Announces Collaboration with Merck to Improve API Manufacturing
Ashland Injectable Excipient Accepted Into FDA Novel Excipient Review Program
MEGGLE Appoints Barentz as its Exclusive Distributor of Pharmaceutical-Grade Lactose for United States
Capsule Excipients
The Evaluation of Dual Laser Handheld Raman Spectroscopy for Identifying Novel Psychoactive Substances
Automated and Rapid Methods to Assess Quality & Stability of Biologics: Recent Developments and Practical Ways to Implement Them in Formulation Development
Drug Delivery Roundtable
Elemental Impurities: Implications for Manufacturers of Drug Products, APIs, and Excipients
Theory of Sampling (TOS) for Development of Spectroscopic Calibration Models
An Interview With Andreas Gryczke, Global Technical Marketing Solubilization BASF Pharma Solutions
The KEY TO Pharma’s Next Generation Success
Key Considerations for Stabilizing Oxidation-Prone Lipid-Based Drug Delivery Systems
DFE Pharma Expands Co-Processed Portfolio
Merck KGaA: Allergopharma Plans to Invest € 40 Million in Production Facility
Expert Presentations at Australia Workshop on Powder Characterisation and Inhaler Testing
CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals with Expanded Content and First Annual Report
BASF pharmaceutical solutions presented at CPhI Worldwide in Frankfurt, Germany
API, Excipient, and Dosage Form Characterization Solutions for the Identity and Control of Critical Quality Attributes (CQA)
Vetter Launches New Clinical Syringe Packages
The New Dawn of Pharmaceutical Manufacturing: Innovative Solutions for Unprecedented Challenges
Colorcon, Inc. Launches First Certified Organic Coating System for Dietary Supplement Tablets
Future of Transdermal Drug Delivery Systems (TDDS)
Are HPLC-UV Methods Fit for Purpose as True Arbiters of Quality for APIs?
A Recent Advancement in Orally Disintegrating Formulations
Tergus Grows Manufacturing Capabilities Tergus Grows Manufacturing Capabilities
Crodasol HS HP
Investigation of Excipient Compatibility and Associated Degradations for the Formulation Development of a Small Molecule Pharmaceutical Compound
Rapid Detection of Counterfeit Drugs of Ethambutol Hydrochloride and Cefuroxime Axetil using Handheld Raman, Near Infrared and Portable FTIR Technologies
Solid State Considerations for Early Development
Utilizing a Novel Disperser Technology to Accelerate Sample Extraction of Pharmaceutical Solid Dosage Forms
“Joshi Capsules” US patent numbers – 8728521 and 9884024
Raw Materials and Functional Excipients Roundtable
ReForm Biologics, MilliporeSigma Announce Licensing Agreement
Recent Innovations in Pharmaceutical Hot Melt Extrusion
Benefits of Using High-Functionality Excipients in a Continuous Manufacturing Process
ABITEC Improves Solubility of Topical, Transdermal Applications with Functional Lipid Excipients
Johnson & Johnson Appoints Senior Leaders to Executive Committee
CURE Pharmaceutical Debuts CUREform Drug Delivery Line
Valneva and IDT Biologika Terminate their COVID-19 Collaboration
New Pancreatic Cancer Drug Receives Orphan Drug Designation by FDA
Roquette Acquires Qualicaps
Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations
Antibody-Drug Conjugates (ADCs): Potent Cancer Killers with PK Challenges
Pharmaceutical P.I.N. Points: Patent Innovation News
Lubrizol Licenses Apisolex Excipient to Welton Pharmaceuticals to Develop Novel Cancer Therapeutic
Reader Quiz: Drug Development Challenges
Vibrational Spectroscopy for the Analysis of Dissolved Active Pharmaceutical Ingredients
VITAMIN C – Tableting with LUBRITAB® RBW Lubricant
Nanoparticle Technologies: Enablers for Ocular Drug Delivery
Pharmaceutical PIN Points
CPhI Japan Postponed
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »
Excipients
Clear
Search By
Keywords
Dosage Form
Process
Apply Changes
Blending
Capsule Filling
Cell Culture
Chelation
Compaction
Direct Compression
Dry Blending
Dry Compression
Dry Granulation
Extrusion
Extrusion spheronisation
Film Coating
Film Formation
Freeze Drying
Hot Melt Extrusion
Injectable Formulation
Melt Coating
Melt Congealing
Melt Spraying
Molecular Encapsulation
Protein Stabilization
Roller Compaction
Sachet Filling
SMEDDS
Solid Lipid Nanoparticles
Solubilization
Spheronization
Spray Congealing
Spray Drying
Supercritical Fluid Extraction
Viscosity Modification
Wet Granulation
Functionality
Apply Changes
Acidifier
Active Pharmaceutical Ingredient
Adhesive
Anti-adherant
Binder
Blending
Capsule Filling
Capsule Shell
Carrier
Cell Culture Ingredient
Co-processed
Coating Systems
Compaction
Controlled Release
Crystallization Inhibitor
Diluent
Direct Compression
Disintegrant
Dispersion
Dry Granulation
Dry Powder Inhalation
Effervescent System
Emulsifier
Extended Drug Release
Filler
Film Formation
Film Former
Flavor
Flow Aid
Freeze Drying
Gastrointestinal Dispersion
Granulation
High-Functionality
Hot Melt Extrusion
Increased Bioavailability
Isotonic Agent
Lipid
Lubricant
Mechanical strength
Modified Release
Multifunctional
Natural Origin
Nutritional Agent
Penetration Enhancer
Permeation Enhancer
pH Modifier
pH regulation
Pigment
Plasticizer
Powder Blends
Preservative
Rapid Release Agent
Sachet Filling
Solubility Enhancement
Solubilizer
Solvent
Spray Drying
Stabilizer
Surfactant
Sustained Release
Sweetener
Tablet Compressibility
Tablet Ejection
Targeted Delivery
Taste Masking
Therapeutic Agent
Thickener
Viscosity Modifier
Wet Binder
Wet Granulation
Dosage Form
Apply Changes
Film
Implant
Liquid
Multiple Dosage Forms
Parenteral
Pulmonary
Semi-solid
Suppository
Tablet
Transdermal
Companies
Apply Changes
BASF North America
Featured Products
PURELAB® Chorus 1 Complete Ultrapure Water System
Labrasol® ALF
Maisine® CC
Connect with Us